Expression of antimicrobial peptides and proteins in etanercept-treated psoriasis patients

Regulatory Peptides

Volumn 167, Issue 2-3, 2011, Pages 163-166

  Gambichler, T ^a   Kobus, S ^a   Kobus, A ^a   Tigges, C ^a   Scola, N ^a   Altmeyer, P ^a   Kreuter, A ^a   Bechara, F G ^a   Skrygan, M ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Antimicrobial peptides; Etanercept; Psoriasis; TNF blockers

Indexed keywords

BETA DEFENSIN 2; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; ETANERCEPT; PSORIASIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; SCORING SYSTEM; SKIN DEFECT; TREATMENT DURATION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; S100 PROTEINS;

EID: 79953217011     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.02.001     Document Type: Article

References (23)

1. Griffiths C.E.M., Barker J.N.W.N. Pathogenesis and clinical features of psoriasis. Lancet 2007, 370:263-271.
2. Büchau A.S., Gallo R.L. Innate immunity and antimicrobial defense systems in psoriasis. Clin Dermatol 2007, 25:616-624.
3. Gambichler T., Skrygan M., Tomi N.S., Othlinghaus N., Brockmeyer N.H., Altmeyer P., Kreuter A. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 2008, 147:17-24.
4. Gambichler T., Skrygan M., Tomi N.S., Altmeyer P., Kreuter A. Changes of antimicrobial peptide mRNA expression in atopic eczema following phototherapy. Br J Dermatol 2006, 155:1275-1278.
5. Gläser R., Meyer-Hoffert U., Harder J., Cordes J., Wittersheim M., Kobliakova J., Fölster-Holst R., Proksch E., Schröder J.M., Schwarz T. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 2009, 129:641-649.
6. Nomura I., Goleva E., Howell M.D., Hamid Q.A., Ong P.Y., Hall C.F., Darst M.A., Gao B., Boguniewicz M., Travers J.B., Leung D.Y. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003, 171:3262-3269.
7. Mossner R., Reich K. Management of severe psoriasis with TNF antagonists. Adalimumab, etanercept and infliximab. Curr Probl Dermatol 2009, 38:107-136.
8. Caproni M., Antiga E., Melani L., Volpi W., Del Bianco E., Fabbri P. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. J Clin Immunol 2009, 29:210-214.
9. Leonardi C.L., Powers J.L., Matheson R.T., Goffe B.S., Zitnik R., Wang A., Gottlieb A.B. Etanercept Psoriasis Study Group. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003, 349:2014-2022.
10. Smith C.H., Anstey A.V., Barker J.N., Burden A.D., Chalmers R.J., Chandler D., Finlay A.Y., Griffiths C.E., Jackson K., McHugh N.J., McKenna K.E., Reynolds N.J., British Association of Dermatologists British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol 2005, 153:486-497.
11. Kienbaum S., Lehmann P., Ruzicka T. Topical calcipotriol in the treatment of intertriginous psoriasis. Br J Dermatol 1996, 135:647-650.
12. Jinquan T., Vorum H., Larsen C.G., et al. Psoriasin: a novel chemotactic protein. J Invest Dermatol 1996, 107:5-10.
13. Harder J., Schröder J.M. Antimicrobial peptides in human skin. Chem Immunol Allergy 2005, 86:22-41.
14. Harder J., Schröder J.M. Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 2005, 77:476-486.
15. Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.H., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007, 449:564-569.
16. Kim B.J., Rho Y.K., Lee H.I., Jeong M.S., Li K., Seo S.J., Kim M.N., Hong C.K. The effect of calcipotriol on the expression of human beta defensin-2 and LL-37 in cultured human keratinocytes. Clin Dev Immunol 2009, 6458987.
17. Hao H.N., Zhao J., Lotoczky G., Grever W.E. Lyman WD Induction of human beta-defensin-2 expression in human astrocytes by lipopolysaccharide and cytokines. J Neurochem 2001, 77:1027-1035.
18. Peric M., Koglin S., Dombrowski Y., et al. Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis. PLoS ONE 2009, 4(7):e6340. [article].
19. Pernet I., Reymermier C., Guezennec A., Branka J.E., Guesnet J., Perrier E., Dezutter-Dambuyant C., Schmitt D., Viac J. Calcium triggers beta-defensin (hBD-2 and hBD-3) and chemokine macrophage inflammatory protein-3 alpha (MIP-3alpha/CCL20) expression in monolayers of activated human keratinocytes. Exp Dermatol 2003, 12:755-760.
20. Seo S.J., Ahn S.W., Hong C.K., Ro B.I. Expressions of beta-defensins in human keratinocyte cell lines. J Dermatol Sci 2001, 27:183-191.
21. Guilloteau K., Paris I., Pedretti N., Boniface K., Juchaux F., Huguier V., Guillet G., Bernard F.X., Lecron J.C., Morel F. Skin inflammation induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1α, and TNF-α recapitulates some features of psoriasis. J Immunol Mar 24 2010, [Epub ahead of print].
22. Martinsson H., Yhr M., Enerbäck C. Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation. Exp Dermatol 2005, 14:161-168.
23. Zaba L.C., Suárez-Fariñas M., Fuentes-Duculan J., Nograles K.E., Guttman-Yassky E., Cardinale I., Lowes M.A., Krueger J.G. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol 2009, 124:1022-1030.e1-395.